Cardio Diagnostics Holdings, Inc. (CDIO)

NASDAQ: CDIO · IEX Real-Time Price · USD

0.510

-0.020 (-3.72%)

At close: Jul 19, 2024, 4:00 PM

0.507

-0.003 (-0.53%)

Pre-market: Jul 22, 2024, 7:00 AM EDT

CDIO Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	0.03	0.02	0	0	0
Revenue Growth (YoY)	3372.95%	1696.32%	5.44%	-	-
Gross Profit	0.03	0.02	0	0	0
Selling, General & Admin	9.64	7.1	4.49	0.57	0.6
Research & Development	0.07	0.15	0.04	0.03	0
Other Operating Expenses	0.02	0.02	0.02	0.02	0.01
Operating Expenses	9.73	7.26	4.55	0.62	0.61
Operating Income	-9.7	-7.24	-4.55	-0.62	-0.61
Interest Expense / Income	1.72	6.74	0	0	0
Other Expense / Income	0.09	-5.6	0.11	-	-0
Pretax Income	-11.51	-8.38	-4.66	-0.62	-0.61
Net Income	-11.51	-8.38	-4.66	-0.62	-0.61
Shares Outstanding (Basic)	21	13	3	1	1
Shares Outstanding (Diluted)	21	13	3	1	1
Shares Change	120.77%	310.83%	165.44%	12.34%	-
EPS (Basic)	-0.75	-0.66	-1.51	-0.53	-0.58
EPS (Diluted)	-0.75	-0.66	-1.51	-0.53	-0.58
Free Cash Flow	-5.85	-6.25	-5.09	-0.59	0.03
Free Cash Flow Per Share	-0.28	-0.49	-1.65	-0.50	0.03
Gross Margin	100.00%	100.00%	100.00%	100.00%	-
Operating Margin	-29392.23%	-42440.43%	-478784.32%	-68862.15%	-
Profit Margin	-34879.52%	-49087.81%	-490630.00%	-68862.15%	-
Free Cash Flow Margin	-17736.51%	-36612.00%	-535891.37%	-64960.16%	-
EBITDA	-9.65	-1.53	-4.64	-0.6	-0.59
EBITDA Margin	-29243.81%	-8966.90%	-488945.79%	-67086.35%	-
Depreciation & Amortization	0.14	0.11	0.02	0.02	0.01
EBIT	-9.78	-1.64	-4.66	-0.62	-0.61
EBIT Margin	-29653.51%	-9620.98%	-490630.00%	-68862.15%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).